(Q80647144)

English

Transitory or long-lasting immunity to Leishmania major infection: the result of immunogenicity and multicomponent properties of histone DNA vaccines

scientific article published on 22 January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18255202%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Transitory or long-lasting immunity to Leishmania major infection: the result of immunogenicity and multicomponent properties of histone DNA vaccines (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18255202%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Leishmania major

object named as

Leishmania major

1 reference

based on heuristic

inferred from title

Javier Carrión

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18255202%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Cristina Folgueira

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18255202%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Carlos Alonso

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18255202%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

22 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18255202%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18255202%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18255202%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18255202%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1155-1165

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18255202%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Recent advances in vaccines for leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Adoptive transfer of dendritic cells pulsed with Leishmania infantum nucleosomal histones confers protection against cutaneous leishmaniosis in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Dendritic cells (DC) activated by CpG DNA ex vivo are potent inducers of host resistance to an intracellular pathogen that is independent of IL-12 derived from the immunizing DC.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Protection against Leishmania major infection by oligomannose-coated liposomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Intraperitoneal immunization with oligomannose-coated liposome-entrapped soluble leishmanial antigen induces antigen-specific T-helper type immune response in BALB/c mice through uptake by peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Heterologous priming-boosting with DNA and modified vaccinia virus Ankara expressing tryparedoxin peroxidase promotes long-term memory against Leishmania major in susceptible BALB/c Mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Immunomodulatory effects associated with a live vaccine against Leishmania major containing CpG oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

DNA vaccines: immunology, application, and optimization*

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Molecular determinants and regulation of Leishmania virulence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Leishmania model for microbial virulence: the relevance of parasite multiplication and pathoantigenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

The nucleosome: from genomic organization to genomic regulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Trypanosomatid histones.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Histone genes in trypanosomatids.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Phylogenetic analysis of the core histones H2A, H2B, H3, and H4

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

The many faces of histone lysine methylation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

The language of covalent histone modifications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Analysis of the humoral immune response against total and recombinant antigens of Leishmania infantum: correlation with disease progression in canine experimental leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Evolutionarily conserved proteins as prominent immunogens during Leishmania infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Antigenicity of the Leishmania infantum histones H2B and H4 during canine viscerocutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Mapping of the linear antigenic determinants from the Leishmania infantum histone H2A recognized by sera from dogs with leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Characterization of the antigenic determinants of the Leishmania infantum histone H3 recognized by antibodies elicited during canine visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Identification of vaccine candidates for experimental visceral leishmaniasis by immunization with sequential fractions of a cDNA expression library

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Vaccination with the divergent portion of the protein histone H2B of Leishmania protects susceptible BALB/c mice against a virulent challenge with Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Expression of a novel Leishmania gene encoding a histone H1-like protein in Leishmania major modulates parasite infectivity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Leishmania histone H1 overexpression delays parasite cell-cycle progression, parasite differentiation and reduces Leishmania infectivity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Protection against cutaneous leishmaniasis in outbred vervet monkeys using a recombinant histone H1 antigen.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Identification and characterization of T cell-stimulating antigens from Leishmania by CD4 T cell expression cloning

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Molecular cloning and analysis of expression of the Leishmania infantum histone H4 genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Immunohistological features of visceral leishmaniasis in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

The role of CD4(+)CD25(+) regulatory T cells in Leishmania infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Immune privilege in sites of chronic infection: Leishmania and regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Conditions influencing the efficacy of vaccination with live organisms against Leishmania major infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Reactivity of autoantibodies in systemic lupus erythematosus with synthetic core histone peptides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Immunogenicity of a multicomponent DNA vaccine against visceral leishmaniasis in dogs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

Mechanism and regulation of immunoglobulin isotype switching.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.051

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2007.12.051

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18255202%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18255202%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80647144&oldid=1816217729"